NCT03998657 - Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

Prostate Cancer

Interventions

DEVICE

Exablate Prostate Treatment

The Exablate system is a non-invasive thermal ablation device that is being used to ablate tissue. The system combines a focused ultrasound surgery (FUS) delivery system and MRI scanner.

Trial Locations (5)

10065

Memorial Sloan-Kettering Cancer Center, New York

33445

Sperling Prostate Center, Delray Beach

55905

Mayo Clinic, Rochester

94305

Stanford University School of Medicine, Stanford

02115

Brigham & Women's Hospital, Boston